Literature DB >> 19492340

A valid equation for the well-stirred perfusion limited physiologically based pharmacokinetic model that consistently accounts for the blood-tissue drug distribution in the organ and the corresponding valid equation for the steady state volume of distribution.

Leonid M Berezhkovskiy1.   

Abstract

A consistent account of the assumptions of the well-stirred perfusion limited model leads to the equation for the organ tissue that does not coincide with that often presented in books and papers. The difference in pharmacokinetic profiles calculated by the valid and the commonly used equations could be quite significant, particularly due to contribution of the organs with relatively large perfusion volume, and especially for drugs with small tissue-plasma partition coefficient and high blood-plasma concentration ratio. Application of the valid equation may result in much faster initial drop of drug plasma concentration time curve and significantly longer terminal half-life, especially for low extraction ratio drugs. An equation for the steady state volume of distribution consistent with the well-stirred model described by the valid equation is provided.

Mesh:

Substances:

Year:  2010        PMID: 19492340     DOI: 10.1002/jps.21798

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Prediction of Pharmacokinetics of IDP-73152 in Humans Using Physiologically-Based Pharmacokinetics.

Authors:  Myongjae Lee; Yoo-Seong Jeong; Min-Soo Kim; Kyung-Mi An; Suk-Jae Chung
Journal:  Pharmaceutics       Date:  2022-05-28       Impact factor: 6.525

2.  Consideration of Fractional Distribution Parameter fd in the Chen and Gross Method for Tissue-to-Plasma Partition Coefficients: Comparison of Several Methods.

Authors:  Yoo-Seong Jeong; William J Jusko
Journal:  Pharm Res       Date:  2022-03-14       Impact factor: 4.580

3.  A mechanistic framework for in vitro-in vivo extrapolation of liver membrane transporters: prediction of drug-drug interaction between rosuvastatin and cyclosporine.

Authors:  M Jamei; F Bajot; S Neuhoff; Z Barter; J Yang; A Rostami-Hodjegan; K Rowland-Yeo
Journal:  Clin Pharmacokinet       Date:  2014-01       Impact factor: 6.447

4.  Physiologically-Based Pharmacokinetic Modeling for Drug-Drug Interactions of Procainamide and N-Acetylprocainamide with Cimetidine, an Inhibitor of rOCT2 and rMATE1, in Rats.

Authors:  Yoo-Seong Jeong; Anusha Balla; Kwang-Hoon Chun; Suk-Jae Chung; Han-Joo Maeng
Journal:  Pharmaceutics       Date:  2019-03-06       Impact factor: 6.321

5.  A hybrid modeling approach for assessing mechanistic models of small molecule partitioning in vivo using a machine learning-integrated modeling platform.

Authors:  Victor Antontsev; Aditya Jagarapu; Yogesh Bundey; Hypatia Hou; Maksim Khotimchenko; Jason Walsh; Jyotika Varshney
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

6.  Development of Physiologically Based Pharmacokinetic Model for Orally Administered Fexuprazan in Humans.

Authors:  Yoo-Seong Jeong; Min-Soo Kim; Nora Lee; Areum Lee; Yoon-Jee Chae; Suk-Jae Chung; Kyeong-Ryoon Lee
Journal:  Pharmaceutics       Date:  2021-05-29       Impact factor: 6.321

7.  A latent variable approach to account for correlated inputs in global sensitivity analysis.

Authors:  Nicola Melillo; Adam S Darwich
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-05-25       Impact factor: 2.745

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.